Healthcare provider profile · identity verified

Princess A Caesar, FNP

Nurse Practitioner · WORCESTER, MA · NPI 1912051491

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	483	24
Quetiapine Fumarate	Quetiapine Fumarate	362	12
Metformin Hcl	Metformin Hcl	355	13
Levothyroxine Sodium	Levothyroxine Sodium	321	11
Divalproex Sodium	Divalproex Sodium	314	suppressed
Trazodone Hcl	Trazodone Hcl	314	13
Lamotrigine	Lamotrigine	280	suppressed
Mirtazapine	Mirtazapine	252	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	250	13
Tamsulosin Hcl	Tamsulosin Hcl	244	11
Risperidone	Risperidone	236	suppressed
Baclofen	Baclofen	229	suppressed
Lisinopril	Lisinopril	229	suppressed
Furosemide	Furosemide	217	13
Olanzapine	Olanzapine	193	suppressed
Gabapentin	Gabapentin	191	11
Amlodipine Besylate	Amlodipine Besylate	189	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	171	suppressed
Eliquis	Apixaban	170	suppressed
Buspirone Hcl	Buspirone Hcl	162	suppressed
Oxcarbazepine	Oxcarbazepine	156	suppressed
Levetiracetam	Levetiracetam	143	suppressed
Simvastatin	Simvastatin	125	suppressed
Prednisone	Prednisone	113	suppressed
Metoprolol Succinate	Metoprolol Succinate	111	suppressed
Haloperidol	Haloperidol	105	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	100	11
Metoclopramide Hcl	Metoclopramide Hcl	100	suppressed
Carbamazepine	Carbamazepine	96	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	91	suppressed
Duloxetine Hcl	Duloxetine Hcl	81	suppressed
Lorazepam	Lorazepam	79	21
Hydrochlorothiazide	Hydrochlorothiazide	77	suppressed
Clonazepam	Clonazepam	73	11
Clopidogrel	Clopidogrel Bisulfate	73	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	70	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	69	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	68	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	68	suppressed
Omeprazole	Omeprazole	60	suppressed
Torsemide	Torsemide	59	suppressed
Aripiprazole	Aripiprazole	57	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	suppressed
Potassium Chloride	Potassium Chloride	55	suppressed
Atenolol	Atenolol	53	suppressed
Propranolol Hcl	Propranolol Hcl	53	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	52	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	52	13
Januvia	Sitagliptin Phosphate	52	suppressed
Lithium Carbonate	Lithium Carbonate	52	suppressed
Ramipril	Ramipril	52	suppressed
Finasteride	Finasteride	51	suppressed
Hydrocortisone	Hydrocortisone	49	suppressed
Riluzole	Riluzole	49	suppressed
Sertraline Hcl	Sertraline Hcl	49	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	48	11
Ondansetron Hcl	Ondansetron Hcl	45	12
Methocarbamol	Methocarbamol	43	suppressed
Primidone	Primidone	42	suppressed
Terazosin Hcl	Terazosin Hcl	41	suppressed
Amiodarone Hcl	Amiodarone Hcl	38	suppressed
Bupropion Hcl	Bupropion Hcl	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	37	suppressed
Glycopyrrolate	Glycopyrrolate	36	suppressed
Scopolamine	Scopolamine	35	suppressed
Tramadol Hcl	Tramadol Hcl	35	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Acarbose	Acarbose	33	suppressed
Divalproex Sodium Er	Divalproex Sodium	33	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	33	suppressed
Santyl	Collagenase Clostridium Hist.	33	12
Colchicine	Colchicine	32	suppressed
Lactulose	Lactulose	32	suppressed
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	15
Doxepin Hcl	Doxepin Hcl	30	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Prazosin Hcl	Prazosin Hcl	30	suppressed
Carvedilol	Carvedilol	28	suppressed
Morphine Sulfate	Morphine Sulfate	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	27	suppressed
Heparin Sodium	Heparin Sodium,porcine	27	suppressed
Lovastatin	Lovastatin	27	suppressed
Budesonide	Budesonide	26	suppressed
Phenytoin	Phenytoin	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Dovato	Dolutegravir Sodium/Lamivudine	25	suppressed
Estradiol	Estradiol	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	13
Benztropine Mesylate	Benztropine Mesylate	20	suppressed
Ertapenem	Ertapenem Sodium	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	18	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Linzess	Linaclotide	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Mupirocin	Mupirocin	16	12
Oxycontin	Oxycodone Hcl	16	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	16	suppressed
Atrovent Hfa	Ipratropium Bromide	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Pentoxifylline	Pentoxifylline	15	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Glipizide	Glipizide	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Paliperidone Er	Paliperidone	11	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error